BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company

  The deal aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the country.

  November 27, 2017

   · 

  4 min read
• BioMidwest

  3D Systems Extends Leadership in Precision Healthcare With Technology Advancements to Quickly Create 3D Models

  The company also announced the industry-first Volume VR technology that allows physicians to upload patient scan data to D2P and immediately visualize medical datasets in virtual reality without time-consuming pre-processing or segmentation.

  November 27, 2017

   · 

  5 min read
• 

  FDA

  IMRIS and Hill-Rom Announce FDA Clearance of New MRI-Conditional Surgical Table for Hybrid OR

  The new surgical table system will be an essential component of the IMRIS Surgical Theatre - a suite of intraoperative imaging technologies that allow neurosurgeons to see critical anatomical detail during surgery, without moving the patient from the operating table.

  November 27, 2017

   · 

  4 min read
• Lone Star Bio

  Acelity: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications

  Study concludes that total arthroplasty patients treated with PREVENA Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing.

  November 27, 2017

   · 

  6 min read
• Business

  Microbix Confirms Ramp-Up of Production

  Microbix’ revenues are mainly from sales of its antigens as critical components for makers of tests that diagnose infectious diseases.

  November 27, 2017

   · 

  4 min read
• Can-Fite Reports Third Quarter 2017 Financial Results & Provides Clinical Update

  Revenues for the nine months ended September 30, 2017 were NIS 2.61 million (U.S. $0.74 million) compared to NIS 0.64 million (U.S. $0.18 million) in the first nine months of 2016.

  November 27, 2017

   · 

  15 min read
• Drug Development

  Seoul National University Hospital Release: Ultraviolet Rays on Your Skin May Exacerbate Your Brain Function

  The research team analyzed neurogenesis as well as the changes in synaptic proteins that connect neurons to neurons in the hippocampus of the brain after irradiating the mouse skin with UV for a total of 6 times over 2 weeks.

  November 27, 2017

   · 

  2 min read
• Business

  Intrexon Announces Key Management Appointments

  Intrexon today announced key executive promotions.

  November 27, 2017

   · 

  6 min read
• Business

  twoXAR Announces Formation of Business Advisory Board

  Industry veterans Judy Lewent, Jonathan MacQuitty, and Howie Rosen bring to twoXAR nearly 90 years of combined R&D and commercial experience in the biopharmaceutical sector.

  November 27, 2017

   · 

  3 min read
• 

  Drug Development

  Catalyst Pharma’s Firdapse Scores Win in Second Phase III LEMS Study

  This trial had two prospectively defined co-primary endpoints.

  November 27, 2017

   · 

  11 min read